Literature DB >> 33488958

Cyclin-Dependent Kinase Inhibitors in Cancer Therapeutics.

Robert B Kargbo1.   

Abstract

Entities:  

Year:  2020        PMID： 33488958      PMCID： PMC7812605          DOI： 10.1021/acsmedchemlett.0c00635

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  6 in total

Review 1.  Getting under the skin: The role of CDK4/6 in melanomas.

Authors:  Linghong Guo; Jinxin Qi; Han Wang; Xian Jiang; Yin Liu
Journal:  Eur J Med Chem       Date:  2020-07-14       Impact factor: 6.514

Review 2.  Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future.

Authors:  Laura M Spring; Seth A Wander; Fabrice Andre; Beverly Moy; Nicholas C Turner; Aditya Bardia
Journal:  Lancet       Date:  2020-03-07       Impact factor: 79.321

Review 3.  Cyclin dependent kinase (CDK) inhibitors as anticancer drugs: Recent advances (2015-2019).

Authors:  Concepción Sánchez-Martínez; María José Lallena; Sonia Gutiérrez Sanfeliciano; Alfonso de Dios
Journal:  Bioorg Med Chem Lett       Date:  2019-08-26       Impact factor: 2.823

Review 4.  Integrating Old and New Paradigms of G1/S Control.

Authors:  Seth M Rubin; Julien Sage; Jan M Skotheim
Journal:  Mol Cell       Date:  2020-09-17       Impact factor: 17.970

Review 5.  CDK7 Inhibitors in Cancer Therapy: The Sweet Smell of Success?

Authors:  Sarah Diab; Mingfeng Yu; Shudong Wang
Journal:  J Med Chem       Date:  2020-03-19       Impact factor: 7.446

Review 6.  Small Molecule CDK Inhibitors for the Therapeutic Management of Cancer.

Authors:  Bharat Goel; Nancy Tripathi; Nivedita Bhardwaj; Shreyans K Jain
Journal:  Curr Top Med Chem       Date:  2020       Impact factor: 3.295
  6 in total
  1 in total

1.  Comprehensive Analysis of Role of Cyclin-Dependent Kinases Family Members in Colorectal Cancer.

Authors:  Liping Guan; Yuanyuan Tang; Guanghua Li; Zhao Qin; Shaoshan Li
Journal:  Front Oncol       Date:  2022-06-22       Impact factor: 5.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.